Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

New role for GLP-1 drugs: Improving survival in people with severe psychiatric disorders

25

Jan 2026

New role for GLP-1 drugs: Improving survival in people with severe psychiatric disorders

This editorial argues that GLP-1 receptor agonists could substantially improve healthspan and reduce premature mortality in people with serious mental illnesses by targeting cardiometabolic risk rather than psychiatric symptoms alone. It highlights emerging evidence, safety considerations, and equity challenges that position GLP-1 RAs as a promising public health strategy for this high-risk population.

Evidence links gut microbiome changes to Alzheimer’s progression

25

Jan 2026

Evidence links gut microbiome changes to Alzheimer’s progression

Human studies consistently report gut microbiome differences in mild cognitive impairment and Alzheimer’s disease, but findings vary widely by cohort, methods, and taxa. Heterogeneity and limited longitudinal data prevent causal inference, highlighting the need for functional profiling and well-designed intervention trials.

Why the age you start smoking matters as much as how much you smoke

25

Jan 2026

Why the age you start smoking matters as much as how much you smoke

Starting smoking at a younger age is associated with substantially higher risks of myocardial infarction, stroke, and death, even after accounting for cumulative smoking exposure. Early initiation also amplifies the cardiovascular harm of heavier smoking, indicating increased vulnerability when smoking begins in adolescence.

The long and short of it: Human penis size evolved for both attraction and rivalry, study suggests

25

Jan 2026

The long and short of it: Human penis size evolved for both attraction and rivalry, study suggests

This experimental study used life-sized and screen-based 3D male avatars to test how penis size, height, and body shape influence female mate choice and male assessments of rivals. The findings show non-linear female preferences for size and demonstrate that penis size functions as a modest but significant cue in male perceptions of fighting ability, alongside stronger traits such as height and torso shape.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Mercury Pharmaceuticals
Mercury Pharmaceuticals

Why Us?

KNOWLEDGE OF RESEARCH ENVIRONMENT

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.

UNDERSTANDING INDUSTRIAL NEEDS

Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.

FOCUSED PROJECT MANAGEMENT

Smart approach to project management that helps speed up development stages and decision making.

INVESTMENT CAPABILITY

Availability of own investment up to 2m€ per project allows us to reach the next value milestone.